Jan Embacher

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Reply to: "Are FIB-4 and liver stiffness measurement interchangeable for HCC risk stratification in MASLD?"

Reply to: "Are FIB-4 and liver stiffness measurement interchangeable for HCC risk stratification in MASLD?"

Journal: JHEP reports : innovation in hepatology

Published: June 07, 2026

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Journal: Annals of hepatology

Published: February 26, 2026

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event.

Journal: Annals of hepatology

Published: February 26, 2026

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation.

Letter: Trajectories of Hepatic Function Markers Enable Early Prediction of Hepatic Recompensation.

Journal: Alimentary pharmacology & therapeutics

Published: December 21, 2025

Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver Disease.

Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 16, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis.

PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis.

Journal: JHEP reports : innovation in hepatology

Published: June 16, 2025

Non-invasive tests to guide hepatocellular carcinoma surveillance.

Non-invasive tests to guide hepatocellular carcinoma surveillance.

Journal: JHEP reports : innovation in hepatology

Published: April 25, 2025

Prevalence of Fibrosis and Applicability of Lab-Based Noninvasive Tests From Primary to Tertiary Care.

Prevalence of Fibrosis and Applicability of Lab-Based Noninvasive Tests From Primary to Tertiary Care.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 26, 2025

Risk of portal hypertensive complications preventable by TIPS in patients with ascites.

Risk of portal hypertensive complications preventable by TIPS in patients with ascites.

Journal: JHEP reports : innovation in hepatology

Published: January 20, 2025

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute Decompensation.

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute Decompensation.

Journal: Alimentary pharmacology & therapeutics

Published: January 14, 2025

Showing 1-12 of 13

Last Updated: 09/26/2026